Transcenta Releases Phase I Clinical Data of TST001 in Combination with CAPOX as the First Line Treatment of Advanced and Metastatic G/GEJ Cancer at ASCO 2022 ...Middle East

SUZHOU, China, June 1, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that clinical...

Read More Details
Finally We wish PressBee provided you with enough information of ( Transcenta Releases Phase I Clinical Data of TST001 in Combination with CAPOX as the First Line Treatment of Advanced and Metastatic G/GEJ Cancer at ASCO 2022 )

Also on site :

• Food Network star Anne Burrell dies aged 55 leaving Worst Cooks in America fans devastated after show absence
• EU state pledges funds to help aspirant counter ‘Russian threats’
• Downtown Lincolnton on lockdown after 'credible threat,' police say no active shooter